Found "Public health policy": 1,085 results
Sort by
Last updated

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients in the Thai healthcare system

The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population health. Recent work in the UK estimated, for the f

Southeast Asia Health Security Roundtable Series: Health system impact of pandemics

Before the pandemic, many countries recognized the importance of regional collaboration in preparing for future pandemics, whether within ASEAN or the broader Asua Pacific region. In 2019, the SSHSPH discussed with the DFAT Australia for funding and support to this initiative, and the onset of the pandemic provided the impetus for it to move forwar

Unlocking Networking, Initiatives, Training, and Expertise (UNITE) for Thailand Leadership in HTA

\"UNITE for Thailand\" is an initiative designed to cultivate the next generation of global health leaders, anchored by the Health Intervention and Technology Assessment Program (HITAP). The proposal acknowledges the critical role of effective leadership in addressing global health challenges and emphasizes the need for proactive support for early

Convergence of Digital Health Platforms and Health Information Systems (HIS) Implementation in Thailand (ConvergeDH) – Year 3

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

Cost-Utility Analysis of Acetylcholinesterase inhibitors in the Treatment of Mild to Moderate Alzheimer’s disease (in Thai language)

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

Assesing a societal value for a ceiling threshod in Thailand (in Thai language)

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

Capcity builiding and Network establishment of Health Intervention and Technology Assesment in Thailand: Phase I (2008-2010)

This project aims to support HITAP ’s capacity building strategy through individual capacity development schemes, for instance, participating in academic conferences, or providing an opportunity to work in and learn from other health technology assessment (HTA ) organizations. In addition, this project included international networking with leadi

Capacity building and Network establishment of Health Intervention and Technology Assessment in Thailand: Phase II (2011-2013)

The project in phase II aims to develop capability in the assessment of health technologies and policies through the activities of capacity building of staff, organization and networks, and to promote the network of the assessment of health technologies and policies in order to make the assessment of health technologies and policies in Thailand as
10 / Page